Advocacy & Policy

Featured Resource
image

Updated Biosimilars Position Paper

Given that more information is now available regarding biosimilars, CAPA has updated its biosimilar position paper as of September 2019.

Looking for updates on CAPA’s advocacy work, meetings, and conferences?

Click here to read our latest newsletter.

  

Advocacy Tips & Tools

Health Policy Information

Backgrounder for Bill C-17

Backgrounder for Bill C-17

Bill C-17 amends the Food and Drugs Act, which hasn’t been substantially updated in over 50 years. It was introduced to the House of Commons by the Minister of Health in December 2013. The Bill has two main goals: Strengthen safety oversight of therapeutic...

read more
Health Canada Information About Opioids

Health Canada Information About Opioids

Pain is the hallmark symptom of the various forms of arthritis. We've been involved in advocating on issues relating to arthritis pain, such as the federal action plan on opioids and the Chronic Pain Research Network. Health Canada information about Opioids Letter to...

read more
How Drugs are Approved in Canada (Video)

How Drugs are Approved in Canada (Video)

The drug development and approval process can be difficult to understand. Below is a video developed by Policy Matters Canada which explains the drug approval process in Canada. CAPA works hard to inform policy-makers why access to approved drugs in...

read more

CAPA Position Papers

Medical Cannabis

Medical Cannabis

Medical cannabis is an important topic for people who live with arthritis and who are looking for ways to relieve their pain. CAPA's position paper is here, and you may also wish to learn more about this topic using resources provided by the Arthritis...

read more
Arthritis Patient Charter

Arthritis Patient Charter

Arthritis Patient Charter The effort to create this Arthritis Patient Charter, once again has been a truly grassroots one, with all groups in the arthritis community working together under CAPA’s leadership. The landscape of arthritis and healthcare...

read more

CAPA Letters to Canadian Governmental Bodies

CAPA Letter on Draft Canadian Drug Pricing Guidelines

CAPA Letter on Draft Canadian Drug Pricing Guidelines

Access to the right medicines is an important component in managing arthritis. In Canada, the Patented Medicines Prices Review Board (PMPRB) plays a key role in drug pricing in Canada. On July 1, 2020, the newly amended Patented Medicines Regulations will...

read more
Safety of Medications and Substances During Pregnancy

Safety of Medications and Substances During Pregnancy

In April 2019, The Hospital for Sick Children (SickKids) in Toronto shut down its Motherisk program. The Motherisk program, initially established in 1985, provided information on the safety of medications and substances during pregnancy. In May, the...

read more

Related CAPA Projects

#ArthritisThenNow Successful Twitter Chat!

#ArthritisThenNow Successful Twitter Chat!

CAPA hosted #ArthritisThenNow Twitter Chat on Saturday, September 26, 2020. The chat was well-attended and had some great discussions about how arthritis treatment, care, and the experience have changed or stayed the same over the past few decades with...

read more
Patient Perspective shared with National Pain Taskforce

Patient Perspective shared with National Pain Taskforce

CAPA Vice-President, Laurie Proulx, presented the patient perspective at a regional consultation for the National Pain Taskforce. You can also write to your Federal Minister of Health to express your support for this government priority by using a letter template we...

read more
Presentation at a Gender and Health Conference

Presentation at a Gender and Health Conference

CAPA President, Linda Wilhelm, presented at a gender and health conference about autoimmune disease, sex, and gender. She spoke about the impact of inflammatory arthritis on a person's life and future areas of research including medication differences...

read more
Presenting CAPA Resources at CRA and PARE 2019

Presenting CAPA Resources at CRA and PARE 2019

Conferences are opportunities for CAPA showcase our tools, research participation and survey results. At the Canadian Rheumatology Association 2019 conference earlier this year, CAPA had the opportunity to present a poster on the various educational...

read more
#ArthritisParent Twitter Chat Results

#ArthritisParent Twitter Chat Results

On September 26, 2018, CAPA hosted a Twitter Chat on arthritis and pregnancy/parenting. #ArthritisParent was a first for CAPA. The results of Twitter Chat were analyzed and presented in a poster at the Canadian Rheumatology Association...

read more
Choosing Wisely Canada

Choosing Wisely Canada

CAPA is a proud partner of the Choosing Wisely Canada (CWC) campaign and its members worked with the Canadian Rheumatology Association on its CWC efforts. The purpose of CWC is to identify unnecessary tests, treatments or procedures, and to help patients and...

read more

When you live with arthritis, information is your most important tool.

The Canadian Arthritis Patient Alliance (CAPA) works with various groups in the arthiritis community to ensure the voice of people living with arthritis is heard and to bring you up-to-date information on issues that affect the arthritis community. We work with healthcare professionals, health organizations, clinicians, industry, health charities, researchers, and various levels of government.

We keep Canadian people living with arthritis and their support groups understand more about their disease and have a voice in managing it.